Partnering

More Topics
thumbnail
Investment
Eyes on Asia: Mulititude out licenses, Huadong bulks up Abs, Merck and KelunEyes on Asia: Multitude out licenses, Huadong bulks up Abs, Merck and Kelun

BioXconomy presents the Asia biopharma and healthcare dealmaking and financing news for the week ending August 25.

byRichard Daverman, Editor
Aug 25, 2024
|
1 Min Read
Abu Dhabi Global Healthcare Week 2024
Partnering
BioNTech: Partnerships are key to deliver drugs at scaleBioNTech: Partnerships are key to deliver drugs at scale
byMillie Nelson
May 20, 2024
1 Min Read
different coloured smoke
Business Strategy
Building successful teams in biotech: “The future is female and very colorful”Building successful teams in biotech
byMillie Nelson
May 7, 2024
1 Min Read
Wedding rings
Partnering
Perfect match: Picking your CDMO is like a marriage, says BayerPicking your CDMO is like a marriage, says Bayer
byMillie Nelson
Apr 11, 2024
1 Min Read
BIO-Europe Spring
Partnering
Competitor today, friend tomorrow: Why partnering is critical for biopharma successWhy partnering is critical for biopharma success
byMillie Nelson
Apr 5, 2024
1 Min Read
Mounajro
Innovation
GLP-1 boom causing pharma players FOMOGLP-1 boom causing pharma players FOMO
byMillie Nelson
Mar 25, 2024
1 Min Read
CEO of Poseida, Kristin Yarema
Business Strategy
Poseida: New CEO, same passion for allogeneic therapies
Poseida: New CEO, same passion for allogeneic therapies
Feb 26, 2024
|
1 Min Read
byMillie Nelson, Editor
Broken heart
Partnering
It’s not me, it’s you! Experts on when you should dump your CDMO
Experts on when you should dump your CDMO
Sep 22, 2023
|
1 Min Read
byMillie Nelson, Editor

BIO-EUROPE COVERAGE

Novo Nordisk sign
Business Strategy
Lessons and blessings: The Novo Nordisk way
Lessons and blessings: The Novo Nordisk way
Michael May, PhD, President, CCRM discusses Canada as a place for life sciences in this video.
Hubs
Bridging AI & Life Sciences, Why Investing in Canada Should Be Your Next Move
Bridging AI & Life Sciences, Why Investing in Canada Should Be Your Next Move
Shaking hands
Partnering
Picky pharma prone to better proven partners amid dealmaking downturn
Picky pharma prone to better proven partners amid dealmaking downturn
Hervé Ansanay, Biotech Alliance Manager, discusses the features of the RESEAU SATT - SATT NETWORK
Hubs
RESEAU SATT, the Best of French Deep Tech
RESEAU SATT, the Best of French Deep Tech

News from APAC

Asia currency
Investment
Eyes on Asia: Sanofi expands China footprint; Takeda buys anemia assetEyes on Asia: Sanofi expands China footprint; Takeda buys anemia asset
byRichard Daverman
Dec 17, 2024
6 Min Read
China on a clock
Investment
A growing phenomenon: The rise of biopharma NewCos in ChinaA growing phenomenon: The rise of biopharma NewCos in China
byRichard Daverman
Dec 13, 2024
7 Min Read
Currency
Investment
Eyes on Asia: Merck and BioNTech land Chinese bispecificsEyes on Asia: Merck and BioNTech land Chinese bispecifics
byRichard Daverman
Dec 4, 2024
4 Min Read
Jan 13 - Jan 15, 2025
An all-inclusive healthcare conference at Hilton Union Square, San Francisco
Register

Recommended

Partnering
Novo’s hunt for genetic med tech drove $600m NanoVation pact
Novo’s hunt for genetic med tech drove $600m NanoVation pact
Plenary at BIO-Europe in Munich
Investment
How industry trends are evolving biotech innovation in 2023
2023 industry trends that helped evolve biotech innovation
three member panel on stage
Innovation
‘Data matters most’ in biotech, and AI is here to help
‘Data matters most’ in biotech, and AI is here to help
Subscribe to Our Newsletters
Stay updated and receive your insights for life sciences investment, innovation and partnering directly in your inbox.
Stay Updated